112 related articles for article (PubMed ID: 37263285)
1. Low HDL Cholesterol Is Associated with Reduced Bleeding Risk in Patients Who Underwent PCI: Findings from the PRACTICE Study.
Zheng YY; Wu TT; Hou XG; Yang Y; Yang HT; Pan Y; Xiu WJ; Ma X; Ma YT; Yang XL; Xie X
Thromb Haemost; 2023 Jul; ():. PubMed ID: 37263285
[TBL] [Abstract][Full Text] [Related]
2. LDL cholesterol levels and in-hospital bleeding in patients on high-intensity antithrombotic therapy: findings from the CCC-ACS project.
Yang Q; Sun D; Pei C; Zeng Y; Wang Z; Li Z; Hao Y; Song X; Li Y; Liu G; Tang Y; Smith SC; Han Y; Huo Y; Ge J; Ma C; Fonarow GC; Morgan L; Liu J; Liu J; Zhou M; Zhao D; Zhou Y; Zhou X;
Eur Heart J; 2021 Aug; 42(33):3175-3186. PubMed ID: 34347859
[TBL] [Abstract][Full Text] [Related]
3. [Association between plasma HDL-C levels and coronary artery severity and impact on outcomes of patients underwent percutaneous coronary intervention].
Song Y; Jiang L; Chen Y; Song L; Zhang Y; Gao LJ; Xu LJ; Chen J; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Feb; 48(2):123-129. PubMed ID: 32135612
[No Abstract] [Full Text] [Related]
4. High-density lipoprotein cholesterol as a predictor of clinical outcomes in patients achieving low-density lipoprotein cholesterol targets with statins after percutaneous coronary intervention.
Seo SM; Choo EH; Koh YS; Park MW; Shin DI; Choi YS; Park HJ; Kim DB; Her SH; Lee JM; Park CS; Kim PJ; Moon KW; Chang K; Kim HY; Yoo KD; Jeon DS; Chung WS; Park YG; Seung KB;
Heart; 2011 Dec; 97(23):1943-50. PubMed ID: 21665885
[TBL] [Abstract][Full Text] [Related]
5. Very high HDL-C (high-density lipoprotein cholesterol) is associated with increased cardiovascular risk in patients with NSTEMI (non-ST-segment elevation myocardial infarction) undergoing PCI (percutaneous coronary intervention).
Chen L; Zhao Y; Wang Z; Wang Y; Bo X; Jiang X; Hao C; Ju C; Qu Y; Dong H
BMC Cardiovasc Disord; 2023 Jul; 23(1):357. PubMed ID: 37461001
[TBL] [Abstract][Full Text] [Related]
6. White Blood Cell Counts to High-Density Lipoprotein Cholesterol Ratio, as a Novel Predictor of Long-Term Adverse Outcomes in Patients After Percutaneous Coronary Intervention: A Retrospective Cohort Study.
Wu TT; Zheng YY; Xiu WJ; Wang WR; Xun YL; Ma YY; Kadir P; Pan Y; Ma YT; Xie X
Front Cardiovasc Med; 2021; 8():616896. PubMed ID: 34307487
[No Abstract] [Full Text] [Related]
7. High-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after percutaneous coronary intervention: a report from the CREDO-Kyoto registry cohort-2.
Izuhara M; Ono K; Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Shizuta S; Tada T; Tazaki J; Horie T; Kuwabara Y; Baba O; Nishino T; Kita T; Kimura T;
Atherosclerosis; 2015 Oct; 242(2):632-8. PubMed ID: 26022139
[TBL] [Abstract][Full Text] [Related]
8. Age and outcomes following personalized antiplatelet therapy in chronic coronary syndrome patients: a post hoc analysis of the randomized PATH-PCI trial.
Pan Y; Wu TT; Hou XG; Yang Y; Deng CJ; Wang S; Zheng YY; Xie X
Platelets; 2023 Dec; 34(1):2206915. PubMed ID: 37154019
[TBL] [Abstract][Full Text] [Related]
9. Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol.
Ogita M; Miyauchi K; Miyazaki T; Naito R; Konishi H; Tsuboi S; Dohi T; Kasai T; Yokoyama T; Okazaki S; Kurata T; Daida H
Heart Vessels; 2014 Jan; 29(1):35-41. PubMed ID: 23516028
[TBL] [Abstract][Full Text] [Related]
10. Sex difference between target levels of cholesterol-related parameters and post-PCI long-term clinical outcomes: From the FU-Registry.
Matsuoka Y; Ike A; Ogawa M; Gondo K; Shirai K; Sugihara M; Nose D; Nishikawa H; Iwata A; Kawamura A; Mori K; Zhang B; Yasunaga S; Miura SI; Saku K
J Cardiol; 2018 Mar; 71(3):259-267. PubMed ID: 29129396
[TBL] [Abstract][Full Text] [Related]
11. Impact of Combined C-Reactive Protein and High-Density Lipoprotein Cholesterol Levels on Long-Term Outcomes in Patients With Coronary Artery Disease After a First Percutaneous Coronary Intervention.
Ogita M; Miyauchi K; Tsuboi S; Shitara J; Endo H; Wada H; Doi S; Naito R; Konishi H; Dohi T; Kasai T; Tamura H; Okazaki S; Suwa S; Daida H
Am J Cardiol; 2015 Oct; 116(7):999-1002. PubMed ID: 26243577
[TBL] [Abstract][Full Text] [Related]
12. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of serum high-density lipoprotein cholesterol level as an independent predictor of one-year mortality after percutaneous coronary interventions.
Ghazzal ZB; Dhawan SS; Sheikh A; Douglas JS; Veledar E; Mavromatis K; Pohlel FK; Vaccarino V
Am J Cardiol; 2009 Apr; 103(7):902-6. PubMed ID: 19327413
[TBL] [Abstract][Full Text] [Related]
14. Associations between lipid profiles and MACE in hemodialysis patients with percutaneous coronary intervention: from the FU-Registry.
Nagata I; Ike A; Nishikawa H; Zhang B; Sugihara M; Mori K; Iwata A; Kawamura A; Shirai K; Uehara Y; Ogawa M; Miura S; Saku K
J Cardiol; 2015 Feb; 65(2):105-11. PubMed ID: 24997801
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
[TBL] [Abstract][Full Text] [Related]
16. Association between high-density lipoprotein cholesterol levels and major adverse cardiovascular events in patients who underwent coronary computed tomography angiography: FU-CCTA registry.
Kawahira Y; Shiga Y; Inoue H; Suematsu Y; Tashiro K; Kato Y; Fujimi K; Takamiya Y; Kuwano T; Sugihara M; Miura SI
Heart Vessels; 2021 Oct; 36(10):1457-1465. PubMed ID: 33744994
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic vs. Bleeding Events of Interruption of Dual Antiplatelet Therapy within 12 Months among Patients with Stent-Driven High Ischemic Risk Definition following PCI.
Wang HY; Xu B; Song CX; Guan CD; Xie LH; Zhao YY; Cai ZX; Yuan S; Dou KF
J Interv Cardiol; 2022; 2022():3895205. PubMed ID: 35095347
[TBL] [Abstract][Full Text] [Related]
18. Low-Density Lipoprotein Cholesterol and Adverse Cardiovascular Events After Percutaneous Coronary Intervention.
Sud M; Han L; Koh M; Abdel-Qadir H; Austin PC; Farkouh ME; Godoy LC; Lawler PR; Udell JA; Wijeysundera HC; Ko DT
J Am Coll Cardiol; 2020 Sep; 76(12):1440-1450. PubMed ID: 32943162
[TBL] [Abstract][Full Text] [Related]
19. High-Density Lipoprotein Cholesterol and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Statins: An Observation from the REAL-CAD Study.
Omote K; Yokota I; Nagai T; Sakuma I; Nakagawa Y; Kamiya K; Iwata H; Miyauchi K; Ozaki Y; Hibi K; Hiro T; Fukumoto Y; Mori H; Hokimoto S; Ohashi Y; Ohtsu H; Ogawa H; Daida H; Iimuro S; Shimokawa H; Saito Y; Kimura T; Matsuzaki M; Nagai R; Anzai T
J Atheroscler Thromb; 2022 Jan; 29(1):50-68. PubMed ID: 33431716
[TBL] [Abstract][Full Text] [Related]
20. Fasting blood glucose to HDL-C ratio as a novel predictor of clinical outcomes in non-diabetic patients after PCI.
Guo QQ; Zheng YY; Tang JN; Wu TT; Yang XM; Zhang ZL; Zhang JC; Yang Y; Hou XG; Cheng MD; Song FH; Liu ZY; Wang K; Jiang LZ; Fan L; Yue XT; Bai Y; Dai XY; Zheng RJ; Xie X; Zhang JY
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33140818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
